English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/83599
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Paradoxical effect of cortistatin treatment and its deficiency on experimental autoimmune encephalomyelitis

AuthorsSouza-Moreira, L.; Morell, M.; Delgado-Maroto, V.; Pedreño, M.; Martinez-Escudero, L.; Caro, Marta; O'Valle, Francisco; Luque, Raúl M.; Gallo, M.; De Lecea, L.; Castaño, Justo P.; González-Rey, Elena
Issue Date2013
PublisherAmerican Association of Immunologists
CitationJournal of Immunology 191: 2144- 2154 (2013)
AbstractCortistatin is a cyclic-neuropeptide produced by brain cortex and immune cells that shows potent anti-inflammatory activity. In this article, we investigated the effect of cortistatin in two models of experimental autoimmune encephalomyelitis (EAE) that mirror chronic and relapsing-remitting multiple sclerosis. A short-term systemic treatment with cortistatin reduced clinical severity and incidence of EAE, the appearance of inflammatory infiltrates in spinal cord, and the subsequent demyelination and axonal damage. This effect was associated with a reduction of the two deleterious components of the disease, namely, the autoimmune and inflammatory response. Cortistatin decreased the presence/activation of encephalitogenic Th1 and Th17 cells in periphery and nervous system, and downregulated various inflammatory mediators, whereas it increased the number of regulatory T cells with suppressive effects on the encephalitogenic response. Moreover, cortistatin regulated glial activity and favored an active program of neuroprotection/regeneration. We further used cortistatin-deficient mice to investigate the role of endogenous cortistatin in the control of immune responses. Surprisingly, cortistatin-deficient mice were partially resistant to EAE and other inflammatory disorders, despite showing competent inflammatory/autoreactive responses. This unexpected phenotype was associated with elevated circulating glucocorticoids and an anxiety-like behavior. Our findings provide a powerful rationale for the assessment of the efficacy of cortistatin as a novel multimodal therapeutic approach to treat multiple sclerosis and identify cortistatin as a key endogenous component of neuroimmune system. Copyright © 2013 by The American Association of Immunologists, Inc.
URIhttp://hdl.handle.net/10261/83599
DOI10.4049/jimmunol.1300384
Identifiersdoi: 10.4049/jimmunol.1300384
issn: 0022-1767
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.